Upcoming webinar
Building skills and workflows in Claude for scientific work using Amass
A live session on writing repetitive scientific work down as skills in Claude, with Amass supplying the trials, papers, patents and approvals behind each step.
Explaining steps to an AI model each time for repetitive work is like working in the lab without a method or protocol. Whether it's screening an asset before a BD call, updating the competitive picture for an indication or checking the evidence behind a target before it goes to the portfolio committee, these tasks can be written down once as a skill: the sources to check, the order, the checks and what the output should look like.
Building on August's session, Kris starts from a blank Claude, connects Amass from Claude's connector directory, and works one research question through by hand. Then he writes what worked into a skill of his own, and links two skills into a workflow that goes from a question to a finished file.
A skill is only as good as what it works from. With Amass connected, each step queries the source records instead of the model's memory: 1.2M+ clinical trials, 43M+ papers, 170M+ patents, 22K+ drugs and molecules, 43K+ genes and the FDA and EMA approvals, with the records behind the answers that you can open and check.
What we will cover
- Connecting Amass in Claude: adding Amass from Claude's connector directory, signing in once with your Amass account, and what its six *Cores add to a skill
- From question to method: working one research question through with Amass and noting the steps that held up
- Writing your own skill: turning those steps into a skill Claude can load, with the sources, the order, the checks and the output
- From skills to a workflow: chaining two skills so one question ends in a finished report or spreadsheet
- Starting from ours: the ready-made Amass skills as templates you can copy and adapt (amass.tech/skills)
- Q&A: ten minutes for a skill or workflow you want to build
Who this is for
Researchers and scientists in drug discovery, clinical development, business development and competitive intelligence, and leaders and decision makers in drug development, who use Claude and want the work they repeat written down as methods.
35 minutes, followed by 10 minutes of Q&A. The session will be recorded.
Hosted by Kris Modig, Scientific Solutions and Enterprise Growth Lead at Amass.
You can connect Amass to Claude for free. Setup takes a few clicks and runs on your existing Amass account: amass.tech/mcp
Meet the speakers
